LRRK2 mutations are found in 4% of hereditary and 1% of sporadic PD patients, and patients with LRRK2 mutations phenocopy sporadic PD patients, with similar onset of disease, α-synuclein pathology, and responsiveness to dopamine replacement [11]. This evidence concerns the gene LRRK2 and Parkinson disease.